Skip to main content
Clinical Trials/NCT01622686
NCT01622686
Completed
Not Applicable

PlainLanguageRx: Improving Medication Labels to Reduce Health Disparities

PictureRx, LLC1 site in 1 country470 target enrollmentNovember 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Health Behavior
Sponsor
PictureRx, LLC
Enrollment
470
Locations
1
Primary Endpoint
Patient understanding of their medication regimen.
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

This randomized controlled trial seeks to test the effect of reformatted prescription drug container labels, compared to usual labels, on participants' understanding of their medications. The study will also assess the effect on self-efficacy and self-reported medication adherence. English and Spanish speaking patients are eligible, with a planned sample size of up to 500 adults.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
May 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
PictureRx, LLC
Responsible Party
Principal Investigator
Principal Investigator

M Brian Riley

Director of Research

PictureRx, LLC

Eligibility Criteria

Inclusion Criteria

  • Be at least 18 years old,
  • Fluency in English or Spanish
  • Manage their own prescription medicines, and
  • Have recently filled at least 1 new prescription medication (e.g, a medicine or medication dose that they have not taken before) and have their new prescription bottle information with them.

Exclusion Criteria

  • Excludes health professionals (such as a doctor, nurse or pharmacist)
  • Too ill to participate in an interview
  • Do not have a telephone
  • Having visual acuity worse than 20/50 via Rosenbaum Visual Acuity exam (eyechart)
  • Persons picking up new medicines for others
  • Inability to communicate in either Spanish or English
  • Overt psychiatric illnesses, overt delirium or dementia

Outcomes

Primary Outcomes

Patient understanding of their medication regimen.

Time Frame: Approximately 7 days

Patient understanding of the instructions for taking their medications correctly.

Secondary Outcomes

  • Self-efficacy(Approximately 7 days)
  • Self-reported adherence(Approximately 7 days)

Study Sites (1)

Loading locations...

Similar Trials